Coloplast Net Income Over Time
| CBHD Stock | EUR 65.64 1.40 2.18% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Coloplast Performance and Coloplast Correlation. Coloplast |
Cross Equities Net Income Analysis
Compare Coloplast AS and related stocks such as Cerence, TELES Informationstech, and BIOTIME Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0S6 | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | (18.3 M) | 45.9 M | (310.8 M) | (56.3 M) | (588.1 M) | (18.7 M) | (16.8 M) | (17.7 M) |
| TLIK | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 521 K | (3 M) | 3.9 M | 824.5 K | 267.5 K | (1.7 M) | (1.9 M) | (835.2 K) | (751.7 K) | (714.1 K) |
| BT3 | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | (20 M) | (46 M) | (11.7 M) | (20.6 M) | (43 M) | (26.3 M) | (21.5 M) | (18.6 M) | (16.7 M) | (17.6 M) |
| MS9 | (487 B) | (487 B) | (487 B) | (487 B) | (155 B) | (758.1 B) | (197.4 B) | (289.3 B) | (228.1 B) | (75.3 B) | (200.1 B) | (181.9 B) | (244.7 B) | (274.8 B) | (116.7 B) | (134.2 B) | (140.9 B) |
| IB5A | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (362.8 M) | (455.6 M) | (397 M) | (275.4 M) | (363.7 M) | (885.7 M) | (589.3 M) | (553.3 M) | (498 M) | (522.9 M) |
| MBJ | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (1.6 B) | (296 M) | (359 M) | (578 M) | (445 M) | (203 M) | (487 M) | (444 M) | (510.6 M) | (536.1 M) |
| MBJ | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (1.6 B) | (296 M) | (359 M) | (578 M) | (445 M) | (203 M) | (487 M) | (444 M) | (510.6 M) | (536.1 M) |
| TZO | (778 K) | (778 K) | (778 K) | (778 K) | (1 M) | (9.6 M) | (2.2 M) | (1.3 M) | (1 M) | (297.6 K) | (654.9 K) | (1.3 M) | (2 M) | (1.2 M) | (1 M) | (1.2 M) | (1.3 M) |
| AJW | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (3.8 B) | (3 B) | (3.8 B) | (4.2 B) | (13.7 B) | (14.7 B) | (7.4 B) | (28.1 B) | (25.3 B) | (24.1 B) |
| 9R5 | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (19.2 M) | (12.2 M) | (10.2 M) | (9.2 M) | (9.6 M) |
Coloplast AS and related stocks such as Cerence, TELES Informationstech, and BIOTIME Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Coloplast AS financial statement analysis. It represents the amount of money remaining after all of Coloplast AS operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Coloplast AS | CBHD |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | Holtedam 1-3, Humlebk, |
| Exchange | Frankfurt Exchange |
EUR 65.64
Other Information on Investing in Coloplast Stock
Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.